| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |